Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Unichem Laboratories Limited ( (IN:UNICHEMLAB) ) just unveiled an announcement.
Unichem Laboratories Limited announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) following an inspection of its Roha API facility. The inspection, conducted in June 2025, was classified as Voluntary Action Initiated (VAI) by the USFDA. This development indicates compliance with regulatory standards, potentially enhancing the company’s credibility and operational standing in the pharmaceutical industry.
More about Unichem Laboratories Limited
Unichem Laboratories Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations. The company is engaged in providing healthcare solutions and has a significant presence in both domestic and international markets.
Average Trading Volume: 4,115
Technical Sentiment Signal: Hold
Current Market Cap: 35.95B INR
See more data about UNICHEMLAB stock on TipRanks’ Stock Analysis page.